See LEGEND for key to shading and symbols.
:: Subject Area - OPTM Term - Semester 2
Data is correct as at Thu 6 Sep 19:04:45 AEST 2018
Comp | Sect | Class | Type | Status | Enr/Cap | % Full | Times (weeks, Location) - default 1hour |
OPTM0001 | Research Thesis Optometry F/T | ||||||
THE | 0001 | 1056 | Enr | Open | 33/2000 | 2% | |
OPTM0002 | Research Thesis Optometry P/T | ||||||
THE | 0001 | 1057 | Enr | Open | 7/2000 | 0% | |
OPTM2233 | Optical Dispensing | ||||||
LAB | GP1 | 9406 | Rel | Open | 22/24 | 92% | Mon 09-11 (w2-9,10-13, OMB G25); Tue 17 (w2-9,10-13, OMB G25) |
LAB | GP2 | 9407 | Rel | Stop | 21/24 | 88% | Mon 11-13 (w2-9,10-13, OMB G25); Wed 12 (w2-9,10-13, OMB G25) |
LAB | GP3 | 9408 | Rel | Stop | 20/24 | 83% | Mon 14-16 (w2-9,10-13, OMB G25); Mon 17 (w2-9,10-13, OMB G25) |
LAB | GP4 | 9409 | Rel | Stop | 24/24 | 100% | Wed 10-12 (w2-9,10-13, OMB G25); Fri 14 (w2-9,10-13, OMB G25) |
LAB | GP5 | 9410 | Rel | Stop | 24/24 | 100% | Wed 13 (w2-9,10-13, OMB G25); Wed 15-17 (w2-9,10-13, OMB G25) |
LAB | GP6 | 9411 | Rel | Open | 16/24 | 67% | Mon 16 (w2-9,10-13, OMB G25); Tue 10-12 (w2-9,10-13, OMB G25) |
LEC | A | 9412 | Enr | Open | 127/140 | 91% | Mon 13 (w1-9,11, ChemSc M18); Thu 15 (w1-9,10, OMB149) |
OPTM3211 | Optometry 3B | ||||||
LAB | GP1 | 5402 | Enr | Stop | 21/24 | 88% | Mon 10-12 (w1-9,11-13, Myers Thtr); Mon 12 (w1-9,11-13, See School); Wed 12-14 (w7-9, Myers 2009); Fri 09 (w2-9,10-13, OMB G25) |
LAB | GP2 | 5403 | Enr | Open | 22/24 | 92% | Mon 10-12 (w1-9,11-13, Myers Thtr); Mon 12 (w1-9,11-13, See School); Tue 09 (w2-9,10-13, OMB G25); Thu 13-15 (w7-9, Myers 2009) |
LAB | GP3 | 5404 | Enr | Open | 17/24 | 71% | Tue 10-12 (w7-9, Myers 2009); Tue 13-15 (w1-9,11-13, Myers Thtr); Tue 15 (w1-9,11-13, See School); Tue 16 (w2-9,10-13, OMB G25) |
LAB | GP4 | 5405 | Enr | Stop | 20/24 | 83% | Tue 13-15 (w1-9,11-13, Myers Thtr); Tue 15 (w1-9,11-13, See School); Tue 16-18 (w7-9, Myers 2009); Wed 09 (w2-9,10-13, OMB G25) |
LEC | A | 5406 | Rel | Open | 80/94 | 85% | Thu 11 (w1-9,10-12, ChemSc M11); Fri 10-12 (w1-8, ChemSc M11); Fri 10-12 (w9,10-12, ChemSc M11) |
OPTM3231 | Ocular Disease 3B | ||||||
LEC | M15A | 5407 | Enr | Open | 91/105 | 87% | Mon 15-17 (w2-3, Vall 121); Mon 15-17 (w4-5,12-13, Vall 121); Mon 15-17 (w6-9,10-11, Vall 121); Wed 14-16 (w2-3, RC Theatre); Wed 14-16 (w4-5,12-13, RC Theatre); Wed 14-16 (w6-9,10-11, RC Theatre); Fri 13 (w2-3, RC Theatre); Fri 13 (w4-5,12-13, RC Theatre); Fri 13 (w6-9,10-11, RC Theatre) |
OPTM4211 | Optometry 4B | ||||||
LA1 | 001 | 9862 | Enr | Open* | 0/5 | 0% | |
OPTM4231 | Clinical Optometry 4B | ||||||
LEC | 001 | 9866 | Enr | Open* | 0/5 | 0% | |
OPTM4251 | Ocular Therapeutics 4B | ||||||
LAB | 001 | 9834 | Enr | Full* | 5/5 | 100% | |
OPTM4271 | Professional Optometry | ||||||
LEC | 001 | 9836 | Enr | Open* | 0/5 | 0% | |
OPTM5211 | Clinical Optometry 5B | ||||||
LEC | 001 | 9903 | Enr | Open | 13/14 | 93% | |
OPTM5231 | Specialist Clinical Optom 5B | ||||||
TUT | 001 | 9904 | Enr | Full | 13/13 | 100% | |
OPTM5251 | Clinical Ocular Therap 5B | ||||||
CLN | 001 | 9902 | Enr | Open | 13/14 | 93% | |
OPTM5271 | Research Project 5B | ||||||
OTH | 001 | 9905 | Enr | Full | 1/1 | 100% | |
OPTM6421 | Binocular, Child, & Low Vision | ||||||
LAB | 501 | 9426 | Rel | Open | 23/24 | 96% | Tue 14-16 (w9,11-12, OMB G25); Tue 14-16 (w8, Myers 2009); Thu 09-11 (w2-4,9,10-13, Myers 2009); Thu 09-11 (w5-8, Myers 2009) |
LAB | 502 | 9427 | Rel | Open | 17/24 | 71% | Fri 12-14 (w9,11-12, OMB G25); Fri 12-14 (w8, Myers 2009); Fri 14-16 (w2-4,9,10-13, Myers 2009); Fri 14-16 (w5-8, Myers 2009) |
LAB | 503 | 9428 | Rel | Open | 22/24 | 92% | Thu 16-18 (w2-4,9,10-13, Myers 2009); Thu 16-18 (w5-8, Myers 2009); Fri 10-12 (w9,11-12, OMB G25); Fri 10-12 (w8, Myers 2009) |
LAB | 504 | 9429 | Rel | Open | 20/24 | 83% | Tue 12-14 (w9,11-12, OMB G25); Tue 12-14 (w8, Myers 2009); Wed 15-17 (w2-4,9,10-13, Myers 2009); Wed 15-17 (w5-8, Myers 2009) |
LAB | 505 | 9430 | Rel | Tent | 0/24 | 0% | Fri 16-18 (w2-4,9,10-13, Myers 2009); Fri 16-18 (w5-8, Myers 2009) |
LEC | A | 9431 | Enr | Open | 82/98 | 84% | Mon 13 (w1-2, OMB 229); Mon 13 (w4,7,12, OMB 229); Tue 17 (w1-9,10-12, OMB 229) |
OPTM6422 | Clinical Optometry 4B | ||||||
LEC | A | 9425 | Enr | Open | 72/80 | 90% | Mon 09 (w2-9,10-13, Myers Thtr) |
OPTM6423 | Posterior Eye Therapeutics | ||||||
LAB | 501 | 9417 | Rel | Open | 18/22 | 82% | Wed 11-13 (w8-9,10-13, OPTM CL) |
LAB | 502 | 9418 | Rel | Open | 17/22 | 77% | Tue 13-15 (w8-9,10-13, OPTM CL) |
LAB | 503 | 9419 | Rel | Open | 15/22 | 68% | Tue 15-17 (w8-9,10-13, OPTM CL) |
LAB | 504 | 9420 | Rel | Open | 18/22 | 82% | Fri 15-17 (w8-9,10-13, OPTM CL) |
LEC | A | 9422 | Enr | Open | 68/88 | 77% | Mon 10-12 (w2-9,10-13, OMB 229) |
OTH | F09A | 9423 | Auto | Open | 68/84 | 81% | Fri 09-11 (w7, Mat 103) |
TUT | 505 | 9421 | Rel | Open | 68/84 | 81% | Fri 09-11 (w5-6, Mat 103) |
OPTM6424 | Professional Optometry | ||||||
LEC | A | 9424 | Enr | Open | 64/90 | 71% | Mon 14-16 (w2-9,10-13, Myers Thtr); Thu 14-16 (w2-9,10-13, Myers Thtr) |
OPTM7003 | Epid of Blinding Eye Diseases | ||||||
LEC | 001 | 10563 | Enr | Open | 9/15 | 60% | |
OPTM7006 | Eye Care Program Management | ||||||
LEC | 001 | 10564 | Enr | Open | 5/10 | 50% | |
OPTM7104 | Adv. Contact Lens Studies 1 | ||||||
LEC | 001 | 10580 | Enr | Open* | 10/30 | 33% | |
OPTM7108 | Research Skills in Optometry | ||||||
LEC | 001 | 10579 | Enr | Open | 2/30 | 7% | |
OPTM7117 | Ocular Therapy 2 | ||||||
LEC | 001 | 10422 | Enr | Open | 17/30 | 57% | |
OPTM7308 | Research Project | ||||||
LEC | 001 | 10578 | Enr | Open | 6/30 | 20% | |
OPTM7521 | Advanced Ocular Disease 2 | ||||||
LEC | 001 | 10602 | Enr | Open | 6/15 | 40% | |
OPTM8521 | Clinical Contact lens | ||||||
TUT | A | 9432 | Enr | Open | 73/75 | 97% | Tue 15:30 (See School) |
OPTM8522 | Clinical Optometry 5B | ||||||
LEC | A | 9433 | Enr | Open | 73/75 | 97% | Mon 17 (w2-9,10-13, Myers Thtr); Fri 13 (w8,12, Myers Thtr); Fri 13 (w2-7,9,10-11,13, Myers 2030) |
OPTM8523 | Clinical Ocular Therapy 5B | ||||||
LEC | 001 | 9901 | Enr | Full | 73/73 | 100% | |
OPTM8528 | Research Project B | ||||||
OTH | 001 | 9906 | Enr | Full | 77/77 | 100% | |
^ top ^ | |||||||
LEGEND | |||||||
* This class requires consent. Students cannot self-enrol. | |||||||
# Timetable clash allowed. | |||||||
/odd Runs in odd weeks only. /even Runs in even weeks only. | |||||||
Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity. | |||||||
Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes. | |||||||
[ ] Class capacity where different from effective capacity. | |||||||
Shaded cells: | LEC | Activity different from previous | |||||
Stop | Status is Stop Further Enrolment, Tentative, Closed or Cancelled | ||||||
100% | Class is full (> 100% means capacity is exceeded) | ||||||
80% | Class is nearly full (80% or more) | ||||||
50% | Class is half full | ||||||
0% | Class is less than half full | ||||||
UNSW Sydney NSW 2052, Australian Telephone: (within Aust) 02 9385 1000, (International) +61 2 9385 1000 CRICOS Provider Code 00098G Authorised by Deputy Vice Chancellor (Academic) & Registrar Privacy Statement Copyright & Disclaimer |